Improved accuracy when testing cancer drugs
A method to more accurately test anti-cancer drugs has now been developed at the Sahlgrenska Academy, University of Gothenburg.
List view / Grid view
A method to more accurately test anti-cancer drugs has now been developed at the Sahlgrenska Academy, University of Gothenburg.
For nearly two decades researchers have sought a way to target an oestrogen receptor in the hope they could improve breast cancer survival, but an article contends that the effort may never pan out.
Scientists at The Scripps Research Institute (TSRI) have made another important advance in HIV vaccine design.
Researchers at the Karolinska Institutet in Sweden have managed to synthesise lung surfactant, a drug used in the care of preterm babies, by mimicking the production of spider silk.
In a new study researchers measured how deposits of the pathological protein tau spread through the brain over the course of Alzheimer’s disease.
In this project, universities and companies across 11 European countries and the US will unite efforts to tailor the development and application of therapies to the individual MS patient.
22 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Research coordinated by Karolinska Institutet have identified a link between defective sucrase-isomaltase gene variants and irritable bowel syndrome...
31 October 2016 | By Niamh Louise Marriott, Digital Content Producer
"In our preclinical assessments of stem cell-derived dopamine neurons we noticed that the outcome in animal models varied dramatically, even though...
11 March 2016 | By Victoria White
Scancell is to collaborate with the Karolinska Institutet to explore the scientific and clinical role of citrullinated proteins in the treatment of cancer...
29 January 2016 | By Victoria White
The lab headed by Thomas Helleday at Karolinska Institutet and Biovica are to collaborate to improve evaluation of new, promising cancer therapies...
15 December 2015 | By Victoria White
A new study, conducted by researchers at the Karolinska Institutet and Gothenburg University, describes a possible mechanism for how the gene variant produces clinical symptoms by affecting levels of specific proteins in the brain...
24 January 2014 | By
Assistant Professor in Chemical Biology, Centre for Advanced Cancer Therapies (ACT), Microbiology, Tumour and Cell Biology (MTC) Dept., Karolinska Institutet